<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.7.2-ppt (info@mypapit.net)" -->
<?xml-stylesheet href="http://www.ctaf.org/feed.css" type="text/css"?>
<?xml-stylesheet href="http://www.ctaf.org/feed-atom.xsl" type="text/xsl"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>California Technology Assessment Forum</title>
    <subtitle>California Technology Assessment Forum</subtitle>
    <link rel="alternate" type="text/html" href="http://www.ctaf.org/"/>
    <id>http://www.ctaf.org/</id>
    <updated>2012-02-04T09:17:10+00:00</updated>
    <generator>FeedCreator 1.7.2-ppt (info@mypapit.net)</generator>
<link rel="self" type="application/atom+xml" href="http://www.ctaf.org/atom.xml" />
    <entry>
        <title>Bronchial Thermoplasty for the Treatment of Severe Asthma - pending final editing</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1381/"/>
        <published>2011-10-19T15:30:00+00:00</published>
        <updated>2011-10-19T15:30:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1381/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>This assessment is pending final editing.</summary>
    </entry>
    <entry>
        <title>Metal on Metal Hip Resurfacing as an alternative to Total Hip Arthroplasty</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1375/"/>
        <published>2011-10-19T16:00:00+00:00</published>
        <updated>2011-10-19T16:00:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1375/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>Metal on metal hip resurfacing using the BHR, Cormet 2000, or Conserve Plus devices does not meet CTAF criteria 3-5 for safety, efficacy and improvement in health outcomes for patients as an alternative to total hip arthroplasty.
&lt;br&gt;&lt;br&gt;
The CTAF Panel voted unanimously to accept the recommendation.</summary>
    </entry>
    <entry>
        <title>Low Dose Spiral Computerized Tomography (LDSCT) Screening for Lung Cancer</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1374/"/>
        <published>2011-10-19T16:00:00+00:00</published>
        <updated>2011-10-19T16:00:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1374/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>The use of LDCT as a screening test for lung cancer in high risk individuals at specialized centers meets CTAF criteria 1-5.
&lt;br&gt;&lt;br&gt;
The CTAF Panel voted nine in favor of the recommendation and three opposed.  The motion carried.</summary>
    </entry>
    <entry>
        <title>CTAF Meeting</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/calendar/detail/1310/"/>
        <published>2011-09-08T16:15:00+00:00</published>
        <updated>2011-09-08T16:15:00+00:00</updated>
        <id>http://www.ctaf.org/content/calendar/detail/1310/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
    </entry>
    <entry>
        <title>CTAF Meeting</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/calendar/detail/1309/"/>
        <published>2011-09-08T16:15:00+00:00</published>
        <updated>2011-09-08T16:15:00+00:00</updated>
        <id>http://www.ctaf.org/content/calendar/detail/1309/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
    </entry>
    <entry>
        <title>CTAF Meeting</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/calendar/detail/1308/"/>
        <published>2011-09-08T16:00:00+00:00</published>
        <updated>2011-09-08T16:00:00+00:00</updated>
        <id>http://www.ctaf.org/content/calendar/detail/1308/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
    </entry>
    <entry>
        <title>Aqueous Shunts for the Treatment of Glaucoma</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1304/"/>
        <published>2011-06-30T03:45:00+00:00</published>
        <updated>2011-06-30T03:45:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1304/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that use of aqueous shunts for the treatment of glaucoma not adequately controlled by medication and / or laser therapy meets CTAF TA Criterion 1 through 5 for safety, effectiveness and improvement in health outcomes.</summary>
    </entry>
    <entry>
        <title>Home Telemonitoring for the Management of Heart Failure</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1303/"/>
        <published>2011-06-30T03:45:00+00:00</published>
        <updated>2011-06-30T03:45:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1303/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that use of home telemonitoring for patients with heart failure does not meet CTAF TA Criterion 3 through 5 for safety, effectiveness and improvement in health outcomes.</summary>
    </entry>
    <entry>
        <title>Cryoballoon Ablation for Atrial Fibrillation</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1302/"/>
        <published>2011-06-30T03:45:00+00:00</published>
        <updated>2011-06-30T03:45:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1302/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that cryoablation as a treatment for atrial fibrillation does not meet meets CTAF TA criteria 4 or 5 for improvement in health outcomes.</summary>
    </entry>
    <entry>
        <title>Stereotactic Body Radiation Therapy for the Treatment of Early Stage Non Small Cell Lung Cancer</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1301/"/>
        <published>2011-06-30T03:30:00+00:00</published>
        <updated>2011-06-30T03:30:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1301/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that stereotactic body radiation therapy for the treatment of early stage non small cell lung cancer in medically inoperable patients with peripheral lesions meets CTAF criteria 2-5 for safety, effectiveness and improvement in outcomes.  
&lt;br&gt;&lt;br&gt;
It is recommended that stereotactic body radiation therapy for the treatment of early stage  non small cell lung cancer in medically inoperable patients with central lesions and medically operable patients  does not meet CTAF TA criteria 2-5, for safety, effectiveness, and improvement in outcomes.</summary>
    </entry>
    <entry>
        <title>Radiofrequency Ablation as a Treatment of Dysplastic Barrett’s Esophagus:  Low Grade Dysplasia</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1300/"/>
        <published>2011-06-30T01:45:00+00:00</published>
        <updated>2011-06-30T01:45:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1300/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>RFA for the treatment of BE does not meet CTAF Criteria 4-5 for the treatment of individuals with low grade dysplasia (LGD).</summary>
    </entry>
    <entry>
        <title>Franklin D. Gilliam, PhD</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/member/detail/1281/"/>
        <published>2011-07-19T03:30:00+00:00</published>
        <updated>2011-07-19T03:30:00+00:00</updated>
        <id>http://www.ctaf.org/content/member/detail/1281/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
    </entry>
    <entry>
        <title>Vitamin D for the Prevention of Osteoporotic Fractures</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1250/"/>
        <published>2011-02-16T18:15:00+00:00</published>
        <updated>2011-02-16T18:15:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1250/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that use of vitamin D combined with calcium meets CTAF TA Criteria 1 through 5 for safety, effectiveness and improvement in health outcomes for the prevention of osteoporotic fractures.</summary>
    </entry>
    <entry>
        <title>Therapeutic Hypothermia Following Cardiac Arrest</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1249/"/>
        <published>2011-02-16T18:15:00+00:00</published>
        <updated>2011-02-16T18:15:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1249/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that use of therapeutic hypothermia in comatose adults following cardiac arrest with a first rhythm of ventricular fibrillation or ventricular tachycardia meets CTAF TA Criteria 1 through 5 for safety, effectiveness and improvement in health outcomes.</summary>
    </entry>
    <entry>
        <title>Vertebroplasty as a Treatment of Osteoporotic Compression Fractures</title>
        <link rel="alternate" type="text/html" href="http://www.ctaf.org/content/assessment/detail/1248/"/>
        <published>2011-02-16T18:15:00+00:00</published>
        <updated>2011-02-16T18:15:00+00:00</updated>
        <id>http://www.ctaf.org/content/assessment/detail/1248/</id>
        <author>
            <name>California Technology Assessment Forum</name>
        </author>
        <summary>It is recommended that vertebroplasty does not meet CTAF criteria 3, 4 or 5 for improvement in health outcomes for the treatment of osteoporotic vertebral compression fractures.</summary>
    </entry>
</feed>

